Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Molecular Scaffolds as Double-Targeting Agents For the Diagnosis and Treatment of Neuroblastoma.

Villaverde G, Alfranca A, Gonzalez-Murillo Á, Melen GJ, Castillo RR, Ramírez M, Baeza A, Vallet-Regí M.

Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3067-3072. doi: 10.1002/anie.201811691. Epub 2019 Jan 9.

PMID:
30537383
2.

G9a Correlates with VLA-4 Integrin and Influences the Migration of Childhood Acute Lymphoblastic Leukemia Cells.

Madrazo E, Ruano D, Abad L, Alonso-Gómez E, Sánchez-Valdepeñas C, González-Murillo Á, Ramírez M, Redondo-Muñoz J.

Cancers (Basel). 2018 Sep 12;10(9). pii: E325. doi: 10.3390/cancers10090325.

3.

Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model.

Fiuza-Luces C, Santos-Lozano A, Llavero F, Campo R, Nogales-Gadea G, Díez-Bermejo J, Baladrón C, González-Murillo Á, Arenas J, Martín MA, Andreu AL, Pinós T, Gálvez BG, López JA, Vázquez J, Zugaza JL, Lucia A.

J Physiol. 2018 Mar 15;596(6):1035-1061. doi: 10.1113/JP275292. Epub 2018 Feb 14.

4.

Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.

Melen GJ, Franco-Luzón L, Ruano D, González-Murillo Á, Alfranca A, Casco F, Lassaletta Á, Alonso M, Madero L, Alemany R, García-Castro J, Ramírez M.

Cancer Lett. 2016 Feb 28;371(2):161-70. doi: 10.1016/j.canlet.2015.11.036. Epub 2015 Dec 3.

PMID:
26655276
5.

Effects of local administration of allogenic adipose tissue-derived mesenchymal stem cells on functional recovery in experimental traumatic brain injury.

Mastro-Martínez I, Pérez-Suárez E, Melen G, González-Murillo Á, Casco F, Lozano-Carbonero N, Gutiérrez-Fernández M, Díez-Tejedor E, Casado-Flores J, Ramírez-Orellana M, Serrano-González A.

Brain Inj. 2015;29(12):1497-510. doi: 10.3109/02699052.2015.1053525. Epub 2015 Aug 5.

PMID:
26287760
6.

Effects of local administration of allogenic adipose tissue-derived mesenchymal stem cells on functional recovery in experimental traumatic brain injury.

Mastro-Martínez I, Pérez-Suárez E, Melen G, González-Murillo Á, Casco F, Lozano-Carbonero N, Gutiérrez-Fernández M, Díez-Tejedor E, Casado-Flores J, Ramírez-Orellana M, Serrano-González A.

Brain Inj. 2015 Aug 5:1-14. [Epub ahead of print]

PMID:
26244701
7.

The NFKB Inducing Kinase Modulates Hematopoiesis During Stress.

González-Murillo Á, Fernández L, Baena S, Melen GJ, Sánchez R, Sánchez-Valdepeñas C, Segovia JC, Liou HC, Schmid R, Madero L, Fresno M, Ramírez M.

Stem Cells. 2015 Sep;33(9):2825-37. doi: 10.1002/stem.2066. Epub 2015 Jun 23.

8.

Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology.

Ramírez M, García-Castro J, Melen GJ, González-Murillo Á, Franco-Luzón L.

Oncolytic Virother. 2015 Oct 14;4:149-55. doi: 10.2147/OV.S66010. eCollection 2015. Review.

9.

Exercise training can induce cardiac autophagy at end-stage chronic conditions: insights from a graft-versus-host-disease mouse model.

Fiuza-Luces C, Delmiro A, Soares-Miranda L, González-Murillo Á, Martínez-Palacios J, Ramírez M, Lucia A, Morán M.

Brain Behav Immun. 2014 Jul;39:56-60. doi: 10.1016/j.bbi.2013.11.007. Epub 2013 Nov 14.

PMID:
24239952
10.

Exercise benefits in chronic graft versus host disease: a murine model study.

Fiuza-Luces C, Soares-Miranda L, González-Murillo A, Palacio JM, Colmenero I, Casco F, Melén GJ, Delmiro A, Morán M, Ramírez M, Lucia A.

Med Sci Sports Exerc. 2013 Sep;45(9):1703-11. doi: 10.1249/MSS.0b013e31828fa004.

PMID:
23954992
11.

Effects of exercise interventions in graft-versus-host disease models.

Fiuza-Luces C, González-Murillo A, Soares-Miranda L, Martínez Palacio J, Colmenero I, Casco F, Melén G, Morán M, Lucia A, Ramírez M.

Cell Transplant. 2013;22(12):2409-20. doi: 10.3727/096368912X658746. Epub 2012 Oct 31.

PMID:
23127525
12.

Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.

González-Murillo A, Lozano ML, Alvarez L, Jacome A, Almarza E, Navarro S, Segovia JC, Hanenberg H, Guenechea G, Bueren JA, Río P.

Hum Gene Ther. 2010 May;21(5):623-30. doi: 10.1089/hum.2009.141.

PMID:
20001454
13.

Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.

Jacome A, Navarro S, Río P, Yañez RM, González-Murillo A, Lozano ML, Lamana ML, Sevilla J, Olive T, Diaz-Heredia C, Badell I, Estella J, Madero L, Guenechea G, Casado J, Segovia JC, Bueren JA.

Mol Ther. 2009 Jun;17(6):1083-92. doi: 10.1038/mt.2009.26. Epub 2009 Mar 10.

14.

In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1.

Río P, Meza NW, González-Murillo A, Navarro S, Alvarez L, Surrallés J, Castella M, Guenechea G, Segovia JC, Hanenberg H, Bueren JA.

Blood. 2008 Dec 15;112(13):4853-61. doi: 10.1182/blood-2008-05-156356. Epub 2008 Sep 23.

15.

Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.

Gonzalez-Murillo A, Lozano ML, Montini E, Bueren JA, Guenechea G.

Blood. 2008 Oct 15;112(8):3138-47. doi: 10.1182/blood-2008-03-142661. Epub 2008 Aug 6.

16.

Lentiviral vector integration sites in human NOD/SCID repopulating cells.

Laufs S, Guenechea G, Gonzalez-Murillo A, Zsuzsanna Nagy K, Luz Lozano M, del Val C, Jonnakuty S, Hotz-Wagenblatt A, Jens Zeller W, Bueren JA, Fruehauf S.

J Gene Med. 2006 Oct;8(10):1197-207.

PMID:
16960916

Supplemental Content

Loading ...
Support Center